Merit Medical Systems Reports 8% Revenue Growth in Q3 and Sets 2026 EPS Guidance
Merit Medical Systems (MMSI) reported third-quarter total revenue of $416 million, representing an 8% increase year-over-year. The company's performance was bolstered by a 9% organic growth rate in constant currency, with foundational product sales growing by 8% and other segments seeing an 11% organic increase. Looking ahead, the company has provided long-term financial targets, aiming for non-GAAP earnings per share (EPS) between $4.33 and $4.37 in 2026. Additionally, Merit Medical expects to add approximately $45 million in revenue through its Solo Pace product line.
Tickers: $MMSI
Topics: earnings report organic growth revenue growth
Read the full article at Seeking Alpha
Part of the story Allstate Reports Q3 2026 Results with Revenue Growth and Increased Policy Volume (20 articles)